U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
183871183871LIFE Study - Limiting Chronotropic Incompetence for Pacemaker RecipientsCompletedNo Results AvailableBradycardiaDevice: sensor programminghttps://ClinicalTrials.gov/show/NCT00146861
183872183872PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization TherapyCompletedHas ResultsHeart FailureDevice: Atrial support pacing through cardiac resynchronization therapy. Device: RENEWAL family of CRT-D deviceshttps://ClinicalTrials.gov/show/NCT00146848
183873183873Post-marketing Safety Study of GSK Biological's Pediarix™ VaccineCompletedNo Results AvailableHepatitis B|Poliomyelitis|Diphtheria|Tetanus|Acellular PertussisBiological: Pediarix|Biological: Licensed DTPa containing vaccine|Biological: Prevnar®: (Wyeth)https://ClinicalTrials.gov/show/NCT00146835
183874183874REFLEx Study (ENDOTAK RELIANCE G Evaluation of Handling and Electrical PerformanceCompletedNo Results AvailableArrhythmiaDevice: ENDOTAK RELIANCE G leadhttps://ClinicalTrials.gov/show/NCT00146822
183875183875Study About Efficacy and Safety to Treat Multi-System-AtrophyCompletedNo Results AvailableMulti-System-Atrophy|MinocyclineDrug: Minocylinehttps://ClinicalTrials.gov/show/NCT00146809
183876183876A Randomised Trial of Rapid Diagnostic Tests in the Diagnosis of Malaria in TanzaniaCompletedNo Results AvailableMalaria|Febrile IllnessDevice: Rapid diagnostic test for malariahttps://ClinicalTrials.gov/show/NCT00146796
183877183877Navrongo Drug Options for IPT in Pregnancy TrialCompletedNo Results AvailableMalariaDrug: Sulphadoxine-pyrimethamine|Drug: Sulphadoxine-pyrimethamine, amodiaquinehttps://ClinicalTrials.gov/show/NCT00146783
183878183878Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) PatientsCompletedHas ResultsMucopolysaccharidosis I|Hurler's Syndrome|Hurler-Scheie Syndrome|Scheie SyndromeBiological: Aldurazyme|Biological: Aldurazyme|Biological: placebohttps://ClinicalTrials.gov/show/NCT00146770
183879183879A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years OldCompletedHas ResultsMucopolysaccharidosis I|Hurler Syndrome|Hurler-Scheie Syndrome|Scheie SyndromeBiological: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)|Biological: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)https://ClinicalTrials.gov/show/NCT00146757
183880183880Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive AdultsCompletedNo Results AvailableTuberculosisBiological: Mtb72F/AS02Ahttps://ClinicalTrials.gov/show/NCT00146744
183881183881A Trial of Antimalarial Drugs Used in Pregnancy in TanzaniaCompletedNo Results AvailableMalariaDrug: SP|Drug: SP + amodiaquine|Drug: AQ + artesunate|Drug: chlorproguanil-dapsonehttps://ClinicalTrials.gov/show/NCT00146731
183882183882Anti-Malarial Drug Resistance in CameroonCompletedNo Results AvailableMalariaDrug: Amodiaquine and Sulphadoxine/Pyrimethamine|Drug: Amodiaquine and sulphadoxine/pyrimethaminehttps://ClinicalTrials.gov/show/NCT00146718
183883183883Long Term Follow-up of Pegylated-Interferon Alpha-2bCompletedNo Results AvailableChronic Hepatitis BProcedure: blood samples are taken oncehttps://ClinicalTrials.gov/show/NCT00146705
183884183884A Trial of Improved Financial Access to Healthcare in GhanaCompletedNo Results AvailableMalariaBehavioral: Free medical treatmenthttps://ClinicalTrials.gov/show/NCT00146692
183885183885Psychoeducational Intervention for ICD Patients (PEACE)CompletedNo Results AvailableHeart Failure|Ventricular ArrhythmiasBehavioral: Psychoeducational Telephone counseling (TC)|Behavioral: Psychoeducational Intervention by Group (SG)|Behavioral: Usual Carehttps://ClinicalTrials.gov/show/NCT00146679
183886183886Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)RecruitingNo Results AvailablePeripheral Arterial Disease|Intermittent ClaudicationDevice: Intermittent compressionhttps://ClinicalTrials.gov/show/NCT00146666
183887183887Heparin Management During Cardiopulmonary Bypass in ChildrenCompletedNo Results AvailablePrimary Condition: Heart Defects Requiring Surgery With CPBhttps://ClinicalTrials.gov/show/NCT00146653
183888183888Prednisone Timed-Release Tablet (TRT) Study: TRT Formulation of Prednisone Compared to Standard Prednisone in Patients With Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisDrug: Prednisonehttps://ClinicalTrials.gov/show/NCT00146640
183889183889Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African TrypanosomiasisCompletedNo Results AvailableTrypanosomiasis, AfricanDrug: Eflornithine|Drug: Nifurtimoxhttps://ClinicalTrials.gov/show/NCT00146627
183890183890Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell TransplantationCompletedNo Results AvailableGraft Versus Host Disease|Hematologic MalignanciesDrug: Sirolimus|Drug: Tacrolimus|Drug: Methotrexate|Procedure: Stem Cell Transplantationhttps://ClinicalTrials.gov/show/NCT00146614
183891183891Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast CancerCompletedNo Results AvailableBreast CancerDrug: Fulvestranthttps://ClinicalTrials.gov/show/NCT00146601
183892183892Cytoxan, Epirubicin and Capecitabine in Women With Breast CancerCompletedNo Results AvailableBreast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast CancerDrug: Cyclophosphamide|Drug: Epirubicin|Drug: Capecitabinehttps://ClinicalTrials.gov/show/NCT00146588
183893183893Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3)CompletedNo Results AvailableCoronary DiseaseDevice: Sirolimus-eluting stent (Cypher)|Device: Paclitaxel-eluting stent (Taxus)https://ClinicalTrials.gov/show/NCT00146575
183894183894Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast CancerCompletedNo Results AvailableBreast Cancer|Stage I Breast Cancer|Stage II Breast CancerDrug: Darbepoetin Alfa|Drug: Pegfilgrastim|Drug: Paclitaxel|Drug: Doxorubicin|Drug: Cyclophosphamidehttps://ClinicalTrials.gov/show/NCT00146562
183895183895Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast CancerCompletedNo Results AvailableBreast Cancer|Stage IV Breast CancerDrug: Trastuzumab|Drug: Vinorelbine|Drug: Paclitaxel|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00146549
183896183896Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional BiopsyCompletedNo Results AvailableBreast Neoplasmshttps://ClinicalTrials.gov/show/NCT00146536
183897183897An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNo Results AvailableMajor Depressive DisorderDrug: Mifepristone|Drug: placebohttps://ClinicalTrials.gov/show/NCT00146523
183898183898HealtheTech Lifestyle ProgramCompletedNo Results AvailableObesityBehavioral: HealtheLifestyle Program|Behavioral: step counters with monthly feedback on logshttps://ClinicalTrials.gov/show/NCT00146510
183899183899Cytokine Change in Bronchoalveolar Lavage Fluid After Early Budesonide-Surfactant Treatment in Premature InfantsTerminatedNo Results AvailablePremature Infants|Respiratory Distress Syndrome|Chronic Lung Disease|Bronchoalveolar Lavage Fluid|CytokinesDrug: Budesonide-Surfactanthttps://ClinicalTrials.gov/show/NCT00146497
183900183900A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 1Drug: Twice Daily versus Three Times Daily Insulin Injectionshttps://ClinicalTrials.gov/show/NCT00146484

* Görseller ve İçerik tekif hakkına sahip olabilir